Breast Cancer - Moose and Doc

A breast cancer explanations website

 

May 6, 2019 By Dr. Halls

 

Back to Invasive Ductal Carcinoma with Central Necrosis

 

References for Invasive Ductal Carcinoma with Central Necrosis

  • Goldstein NS, Murphy T. (1996) Intraductal carcinoma associated with invasive carcinoma of the breast: a comparison of the two lesions with implications for intraductal carcinoma classification systems. Am J Clin Pathol. 1996;106:312-318. https://www.ncbi.nlm.nih.gov/pubmed/8816587
  • Gupta SK, Douglas-Jones AG, Fenn N. (et al). (1997) The clinical behaviour of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ). Cancer. 1997;80:1740-1745.
  • Holland R, Peterse JL, Millis RR. (et al). (1994) Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol. 1994;11:167-180. https://www.ncbi.nlm.nih.gov/pubmed/7831528
  • Jimenex RE, Wallis T, Visscher D. (2001) Centrally Necrotizing Carcinomas of the Breast: A Distinct Histologic Subtype With Aggressive Clinical Behavior. Amer ican Journal of Surgical Pathology: (March 2001) Volume 25 – Issue 3 – pp 331-337 https://www.ncbi.nlm.nih.gov/pubmed/11224603
  • Leonard GD, Swain SM (2004) Ductal carcinoma in Situ, Complexities and Challenges. Natl Cancer Inst 2004 , 16; 96:906-20. https://academic.oup.com/jnci/article/96/12/906/2520795/Ductal-Carcinoma-In-Situ-Complexities-and
  • Leong AS, Sormunen RT, Vinyuvat S, Hamdani RW, Suthipintawong C. (2001) Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems. Am J Clin Pathol 2001, 115:709-18. https://www.ncbi.nlm.nih.gov/pubmed/11345835
  • Leong AS-Y, Vinyuvat S, Suthipintawong C. (et al). (1995) A comparative study of cell proliferation markers in breast carcinomas. J Clin Pathol Mol Pathol. 1995;48:M83-M87. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC407930/
  • Luke C, Priest K, Roder D (2006) Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening. Asian Pac J Cancer Prev 2006 , 7:69-74.
    https://www.ncbi.nlm.nih.gov/pubmed/16629519
  • Page DL, Dupont WD, Rogers LW. (et al). (1995) Continued local recurrence of carcinoma 15-25 years after a diagnosis of lowgrade ductal carcinoma in situ of the breast treated by biopsy. Cancer. 1995;76:1197-1200. https://www.ncbi.nlm.nih.gov/pubmed/8630897
  • Perin T, Canzonieri V, Massarut S. (et al). (1996) Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast. Eur J Cancer. 1996;32A:1148- 1155. https://www.ncbi.nlm.nih.gov/pubmed/8758245
  • Pervez S, Khan H. (2007) Infiltrating ductal carcinoma breast with central necrosis closely mimicking ductal carcinoma in situ (comedo type): a case series. J Med Case Reports. 2007 Sep 8;1:83.
    https://jmedicalcasereports.biomedcentral.com/articles/10.1186/1752-1947-1-83
  • Rosser RJ (1998) Consensus conference on the classification of ductal carcinoma in situ. Cancer. 1998 Jun 1;82(11):2293-5. https://www.ncbi.nlm.nih.gov/pubmed/9610713
  • Thompson EW, Torri J, Sabol M. (et al). (1994) Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin Exp Metastasis. 1994;12:181-194. https://www.ncbi.nlm.nih.gov/pubmed/8194193
  • Wick MR, Ockner DM, Mills SE, Ritter JH, Swanson PE. (1998) Homologous carcinomas of the breasts, skin and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma and salivary duct carcinoma. Am J Clin Pathol 1998 , 109:75-84. https://www.ncbi.nlm.nih.gov/pubmed/9426521
  • Yaziji H, Gown AM, Sneige N. (2000) Detection of stromal invasion in breast cancer: the myoepithelial markers. Adv Anat Pathol 2000 , 7:100-109. https://www.ncbi.nlm.nih.gov/pubmed/10721417

 

Back to Invasive Ductal Carcinoma with Central Necrosis

 

 

Copyright © 2000–2025 · by Steven Halls, MD · [email protected] · 1-780-608-9141 · Contact, Privacy, Terms